Empowering Healthcare through AI Precision and Global Integration
Business Units
Why
Units?
ETAO International strategically organizes its operations into specialized business units, each designed to leverage cutting-edge AI technology and integrated healthcare solutions to maximize patient outcomes and shareholder value.
Business Units Overview
AI Precision Medicine Platform
Genomic sequencing and molecular diagnostics
AI-assisted clinical decision support
Innovative therapies for targeted treatment
Smart Health Media
Virtual consultations and remote patient monitoring
AI-driven diagnostic tools and predictive analytics
Digital healthcare apps for patient engagement
Digital Dental Solutions
Wellness and preventive care programs
Health education and patient support initiatives
Complementary health products and services
Sino-U.S. Oncology Ecosystem
Sino-U.S. Joint Cancer Treatment Centers: Cross-border cancer diagnostics and therapy
Urgent Care Network: Cash-flow positive emergency care clinics
XYST1N Nurse Resource Platform: Bridging nursing resource gaps between Asia and the U.S.
AI Precision Medicine Platform
Utilizing advanced AI algorithms and precise diagnostics to deliver personalized healthcare solutions, aiming to improve clinical outcomes and reduce treatment times.
Core Assets and Companies:
-
DiaCarta (California, USA): Specializes in precision molecular diagnostics, gene-level oncology testing, and tumor detection.
-
Alpha Biopharma (Suzhou, China): Developer of innovative oncology therapeutics, including Zoritinib—the first EGFR-targeting drug capable of penetrating brain metastases.
-
QX Therapeutics (USA): Developing advanced therapies for Acute Respiratory Distress Syndrome (ARDS), significantly enhancing critical care outcomes.
Strategic Advantages:
-
Proprietary global patents securing high technical barriers.
-
Specialized orphan-drug development with significant market differentiation and premium pricing.
Smart Health Media
Delivering healthcare services directly to patients via innovative digital platforms, telehealth solutions, and virtual consultations, thereby increasing accessibility and convenience.
Core Assets and Companies:
-
Hulu Avatar (Hangzhou, China): AI-based virtual healthcare assistants offering personalized health content and digital healthcare solutions.
-
Eureka Systems (Shanghai, China): Smart healthcare management and telehealth platforms, facilitating comprehensive patient care and medical data integration at the regional level (PaaS and SaaS solutions).
-
Strategic Advantages:
-
Seamless integration of AI and telemedicine solutions to enhance patient interaction and clinical workflows.
-
Expansion into digital subscription models enhancing patient accessibility and retention.
Digital Dental Solutions
Driving innovation in dental care through digital platforms, robotics, AI diagnostics, and vertically integrated dental services.
Core Assets and Companies:
-
6D Dental (Hangzhou, China): Pioneers AI-powered dental imaging, diagnostics, and SaaS-based dental platform services.
-
International Dental Certification and standardization body ensuring high-quality standards and global integration.
-
Integrated vertical chain linking materials manufacturing, equipment, clinical services, education, and training into a cohesive dental industry value chain.
Strategic Advantages:
-
Integrated subscription-based model creating high-margin revenue streams.
-
Rapid scalability and international market penetration.
Sino–U.S. Oncology Ecosystem
Establishing comprehensive cross-border cancer treatment centers integrating Sino-U.S. oncology expertise, remote medical services, and specialized nursing solutions.
Core Assets and Companies:
-
Sino-U.S. Joint Cancer Treatment Centers (Hainan, China & California, USA): Integrated centers combining remote and in-person cancer diagnostics and treatments, jointly developed with international oncology institutions.
-
Urgent Care Network (USA): Cash-flow-positive chain of urgent care clinics providing stable operational revenue and serving as training bases.
-
XYST1N Nurse Resource Platform (USA & Asia): End-to-end platform solving critical nursing shortages in the U.S. through training, licensing, and cross-border staffing solutions.
Strategic Advantages:
-
Unique Sino-U.S. collaboration model enhancing cross-border patient care and treatment efficacy.
-
Innovative nurse-staffing model addressing critical healthcare workforce shortages, significantly improving operational capabilities and revenue opportunities.
Synergies Across Units
Each SBU within ETAO strategically complements the others, driving a fully integrated patient-care model from early screening and precise diagnostics through specialized treatments and comprehensive aftercare. This creates a uniquely holistic healthcare approach supported by digital integration, clinical expertise, and operational efficiency.